Structural Protein News and Research

RSS
Paxlovid resistance associated with SARS-CoV-2 3CLpro mutations

Paxlovid resistance associated with SARS-CoV-2 3CLpro mutations

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

Genome analysis of alphacoronavirus and betacoronavirus species from South Korean bats

A cancer patient who had SARS-CoV-2 for over eight months

A cancer patient who had SARS-CoV-2 for over eight months

SARS-CoV-2 evades natural killer cell cytotoxic responses

SARS-CoV-2 evades natural killer cell cytotoxic responses

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

NSP1 found to act as an immune evasion factor in SARS-CoV-2 infections

Scientists characterize type I IFN response during SARS-CoV-2 infection

Scientists characterize type I IFN response during SARS-CoV-2 infection

Study identifies interesting sequence features in SARS-CoV-2 at start of COVID pandemic

Study identifies interesting sequence features in SARS-CoV-2 at start of COVID pandemic

Stress protein in fibroblasts appears to be an attractive cancer drug target

Stress protein in fibroblasts appears to be an attractive cancer drug target

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine

The frequency and nature of RNA errors in both SARS-CoV-2 and its vaccine

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Study explores the substrate selectivity of the SARS-CoV-2 replicase

Study explores the substrate selectivity of the SARS-CoV-2 replicase

Vaccinated individuals with SARS-CoV-2 infection develop virus-specific T cells inside their noses

Vaccinated individuals with SARS-CoV-2 infection develop virus-specific T cells inside their noses

Researchers explore broad-based immunity against potentially pandemic-causing viruses

Researchers explore broad-based immunity against potentially pandemic-causing viruses

Characterizing SARS-CoV-2 non-structural protein 15 endoribonuclease variants

Characterizing SARS-CoV-2 non-structural protein 15 endoribonuclease variants

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study assesses the efficacy and safety of lithium treatment in patients infected with severe SARS-CoV-2

Study investigates stress granule formation during infection with the human common cold coronavirus and SARS-CoV-2

Study investigates stress granule formation during infection with the human common cold coronavirus and SARS-CoV-2

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

Study identifies two new Omicron lineages associated with a resurgence in infections in South Africa

SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein

SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein

Longitudinal and proteome-wide analysis of antibodies in COVID-19 patients using a SARS-CoV-2 proteome microarray

Longitudinal and proteome-wide analysis of antibodies in COVID-19 patients using a SARS-CoV-2 proteome microarray

Potential diagnostic method for identifying human health-relevant nucleic acids utilizing FokI-assisted digestion of DNA duplexes and DNA/RNA hybrids

Potential diagnostic method for identifying human health-relevant nucleic acids utilizing FokI-assisted digestion of DNA duplexes and DNA/RNA hybrids

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.